Cardiogenic shock and heart failure post-percutaneous coronary intervention in ST-elevation myocardial infarction: Observations from "assessment of Pexelizumab in Acute Myocardial Infarction"
Angioplasty, Balloon, Coronary
Outcome Assessment (Health Care)
Survival after CS remains poor despite aggressive reperfusion. Both CS and CHF remain the major causes of death among STEMI patients undergoing primary PCI. Future studies should examine treatments that aim to reduce mortality in these highest risk patients.